When Julie Jacobs inherits a key to a safety deposit box in Siena, Italy, she is told it will lead her to an old family treasure. Soon she is launched on a perilous journey into the history of her ancestors. Julie encounters descendants from Shakespeare’s unforgettable blood feud, and soon realizes that the old curse is still at work, and that she is the next target. The only one who can save Julie from her fate is Romeo… but where is he? Learn more about this Book and Author: http://www.JulietBook.com Fiction
This 10 minute documentary was shot and collaborated by Shaun Filer, along with the backing of footage by key sources, was edited and scored by Liam Key.
It is an eye opener to the unaware, of the extreme dangers journalists are exposed to when sent to foreign countries. With many infamous journalists baring their most personal experiences, and how it affected their life from then on. Journalists from World War 1, World 2, Vietnam, Baulkens War, Cambodia, Sierre Leone, Palestine, Afghanistan, and finally the epitome of dangerous modern journalism - Iraq.
This upload is for a single event taking place on the 10th September 2008. It will be removed after this one screening, due to the nature and the subjects screened in this documentary.
All care was taken to be balanced and precise. It is about the exposition of dangers, as opposed to the glorification of a video.
Charles-Henri Sabet, the founder of Synthesis Bank Geneva, at the time the leading Swiss online bank and the Rowland Family, British owners of Banque Havilland in Luxembourg and Monaco, have increased the capital of Jiffix Markets Ltd, making the company one of the strongest capitalized online forex companies in Cyprus.
The Board of Jiffix Markets Ltd will benefit from the arrival of Charles–Henri Sabet as Chairman of the Board, who built his reputation in online banking and from Jean-François Willems, CEO of Bank Havilland, one of the most successful private banks in Luxembourg. Their combined experience in key banking sectors will propel JFX.com to the highest level in the industry.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/jiffix-market-ltd/56564/
http://www.jeffusner.com - To Learn How
Jeff Creates Up to 500,000 leads a month or more in his businesses - In
this video Jeff Usner shares a confession of how he has made millions
on the internet without some key skills or secrets that most others
have.
On World Mental Health Day, Janssen has announced the results of a pan-European research project: ‘Talking About Treatment in Schizophrenia: A Patient and Carer Survey’. The survey of 166 adults living with schizophrenia and 468 carers was conducted by the independent market research agency, Fieldwork International (part of Ipsos MORI), and explored awareness, feelings and preferences regarding treatment.
The survey, conducted across 12 countries in Europe (Austria, Belgium, Denmark, France, Germany, Italy, Netherlands, Russia, Spain, Sweden, Switzerland and the UK), highlighted key factors affecting the peace of mind for carers, such as the impact of the condition on day‑to-day life, potential relapse/hospitalisation and getting support beyond medication. 94% stated they reminded the person they care for to take their medication and for 49% this happens often.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7947151-janssen-survey-carers-adults-schizophrenia/
Janssen Healthcare Innovation, a team within Janssen Research & Development, LLC (Janssen), today announced Discharge Decision Support System (D2S2) is the winner of the crowdsourcing-inspired Janssen Connected Care Challenge and the $100,000 prize. D2S2 is a discharge decision support system that uses a proprietary algorithm to assemble and score key data upon hospital admission in order to identify patients who should be referred to post-acute care services to reduce the risk of 30-day readmissions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56342-discharge-decision-support-system-janssen-connected-care-challenge
Investment in basic research, convergence across disciplines and better engagement between academia and industry are key to the future of innovation, according to a panel of renowned thought leaders speaking at the celebration of the 2013 Dr. Paul Janssen Award for Biomedical Research.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63340-johnson-and-johnson-dr-paul-janssen-global-innovation-thermosensation
Kelley Blue Book’s VP and Editorial Director, Jack Nerad introduces the Mercedes Maybach S-Class, Honda’s Newest Crossover the HR-V, Scion’s iM Concept, and Nissan’s "Self-Cleaning" electric Leaf.
2016 Mercedes-Maybach S600
With the world premiere in Guangzhou and the presentation in Los Angeles, the new Mercedes-Maybach S-Class was unveiled almost simultaneously in its two key markets of China and the USA. The US will launch with the Mercedes- Maybach S600 in April 2015.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7384551-los-angeles-auto-show-laas-2015/
The IV Eurasian Higher Education Leaders Forum (EHELF) took place at Nazarbayev University, Astana, Kazakhstan, June 10-12. Each year, more than 300 attendees, industry leaders, from different parts of the world participate in discussions and panel sessions at EHELF.
The theme of this year’s Forum was “Graduate Employability in the 21st Century: key competencies and modern labor market.” “Nazarbayev University took the initiative and created EHELF, a platform for discussing pressing issues in higher education in Kazakhstan as well as globally. Our Steering Committee researches and chooses the most relevant topics for the Forum each year. The topic of EHELF-2015, employability of graduates, employment and labor market, is relevant for us,” - says Shigeo Katsu, the President of Nazarbayev University. “Nazarbayev University is a unique university established in partnerships with some of the world’s best universities. And this year, we are graduating our first cohort of 446 undergraduate and graduate students. And, as the majority of our students will hit the job market, it is very important for us to understand whether our students meet the demands of industry and business, and how we should reflect these demands in our programs” – concluded Katsu.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7553651-iv-ehelf-astana-nazarbayev-university/
Apurado. Lifting. Enojado. Raining. Tranquilo. Keyless Entry disponible en el nuevo Ford Fiesta siempre es útil. - Check out how Alex gets inside a new Fiesta enacting all kinds of moods and always without reaching for the key.
Current drug shortages in the U.S., while disruptive and of increasing concern to patients, clinicians and policymakers, are limited primarily to generic injectables and a few key disease areas, according to an IMS Institute for Healthcare Informatics study released today. The new study, Drug Shortages: A Closer Look at Products, Suppliers and Volume Volatility, offers a comprehensive examination of drug shortages and recommends that healthcare stakeholders work toward the creation of an early warning system to minimize future patient care disruptions.
To multimedia News Release, go to http://www.multivu.com/mnr/53215-ims-institute-for-healthcare-informatics-drug-shortage-study
Takeda today announced the launch of a new expert Report on COPD, introduced at a Takeda organised press conference on the occasion of the 2012 European Respiratory Society (ERS) Annual Congress taking place from 1- 5 September in Vienna, Austria.
The Report, entitled ‘The Shifting Paradigm in Chronic Obstructive Pulmonary Disease (COPD) Management,’ was initiated and developed by Takeda Pharmaceuticals International GmbH and is a compilation of opinion articles from a panel of key international respiratory experts, the European Federation of Allergy and Airways Diseases Patients’ Association (EFA) and COPD patients, reflecting updated guidance and research. The new expert Report was developed in response to a recent shift in emphasis in COPD management which now places future risk at equal importance to treatment of current disability. Treatment objectives are now divided into two groups: reducing symptoms and reducing risk.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56582-expert-report-on-copd-launch
